成功运用协同静脉注射链霉素治疗血液透析患者难治性粪肠球菌菌血症。

A successful strategy for the use of synergistic intravenous streptomycin in a hemodialysis patient with refractory Enterococcus faecalis bacteremia.

机构信息

Division of Infectious Diseases, Department of Medicine, Denver Health Medical Center, 777 Bannock St, MC 4000, Denver, CO 80204, USA.

出版信息

J Infect Chemother. 2011 Oct;17(5):698-9. doi: 10.1007/s10156-011-0226-1. Epub 2011 Feb 25.

DOI:10.1007/s10156-011-0226-1

PMID:21350946

Abstract

Streptomycin has been available for over 60 years, yet optimal dosing in hemodialysis (HD) patients is not well defined. We report the successful treatment of enterococcal bacteremia in an HD patient with intravenous (IV) penicillin G and IV streptomycin at a dose of 7.5 mg/kg after HD sessions.

摘要

链霉素已经问世超过 60 年，但在血液透析（HD）患者中，最佳剂量尚未明确界定。我们报告了一例 HD 患者静脉注射（IV）青霉素 G 和 IV 链霉素 7.5mg/kg 的成功治疗方案，用于治疗肠球菌菌血症。